TickerFacts.

Longeveron Inc. (LGVN): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$800.0K
Year ended 2025-12-31
$800.0K
Trailing 12 months to 2026-06-30
+4.6%
3-year compound annual growth
n/m
5-year compound annual growth
2020-12-31: $12021-12-31: $12022-12-31: $700.0K2023-12-31: $700.0K2024-12-31: $700.0K2025-12-31: $800.0K$800.0K
2020-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$800.0K+14.3%2026-03-17, From 2025-01-01
2024-12-31$700.0K0.0%2026-03-17, From 2024-01-01
2023-12-31$700.0K0.0%2025-02-28, From 2023-01-01
2022-12-31$700.0Kn/m2024-02-27, From 2022-01-01
2021-12-31$10.0%2023-03-14, From 2021-01-01
2020-12-31$1n/a2022-03-11, From 2020-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Longeveron Inc. (LGVN)2025-12-31$800.0K+14.3%
Neuphoria Therapeutics Inc. (NEUP)2026-06-30$663.0K0.0%
China SXT Pharmaceuticals, Inc. (SXTC)2026-03-31$73.7K-10.5%
Vistagen Therapeutics, Inc. (VTGN)2026-03-31$199.0K+32.7%
IGC Pharma, Inc. (IGC)2025-03-31$618.0K-3.0%
Cannapharmarx, Inc. (CPMD)2024-12-31$0-100.0%
Northwest Biotherapeutics Inc (NWBO)2025-12-31$2.06M+18.3%
Dare Bioscience, Inc. (DARE)2025-12-31$1.63Mn/m
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$43.3K+269.5%

Compare LGVN, NEUP, SXTC, VTGN side by side · Screen every company in Pharmaceutical Preparations ↗